Sakar Healthcare Limited
₹1,158.55
+3.69%
Delayed · cached 15 min
Fair value analysis
SAKAR
Sakar Healthcare Limited
₹1,117.30
Close used for this calculation
₹491.86Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
49/100
Quality radar
Consensus fair value
₹491.86
Above FV▼ -56.0% against the close used
Model range ₹166.34 – ₹694.74
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹166.34Fair value₹491.86Bull₹694.74
FairClose
52-week traded range
52W low ₹334.3052W high ₹1,157.85
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Sakar Healthcare Limited closed at ₹1,117.30, 127.2% above the consensus fair value of ₹491.86 drawn from 9 valuation models.
Financial DNA score 49/100 — Average. P/E of 71.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹180.65
-83.8%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹226.72
-79.7%
√(22.5 × EPS × BVPS)
EPS=13.7, BVPS=166.76 · outside Graham range (P/E 71.4, P/B 6.7) — asset-light, treat as a rough floor
Graham Formula
₹616.99
-44.8%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=20%, FD=7%
P/E Fair Value
₹489.09
-56.2%
EPS × 35.7x (sector P/E)
EPS=13.7, Sector P/E=35.7x
Peter Lynch (PEG)
₹342.50
-69.3%
EPS × Growth% (PEG = 1 is fair)
EPS=13.7, g=25%
EV/EBITDA
₹694.74
-37.8%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=930M
Book Value (P/B)
₹166.34
-85.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=166.76, ROE=10%, g=6%, r=10%
Reverse DCF
₹1,117.30
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 26.3% | Historical: 25%
Margin of Safety
₹283.77
-74.6%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=378.36, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.